ATE250057T1 - Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten - Google Patents

Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten

Info

Publication number
ATE250057T1
ATE250057T1 AT99941269T AT99941269T ATE250057T1 AT E250057 T1 ATE250057 T1 AT E250057T1 AT 99941269 T AT99941269 T AT 99941269T AT 99941269 T AT99941269 T AT 99941269T AT E250057 T1 ATE250057 T1 AT E250057T1
Authority
AT
Austria
Prior art keywords
derivatives
benzoquinolizin
producing
compounds
formula
Prior art date
Application number
AT99941269T
Other languages
English (en)
Inventor
Antonio Guarna
Mario Serio
Ernesto Giovanni Occhiato
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE250057T1 publication Critical patent/ATE250057T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99941269T 1998-08-03 1999-07-23 Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten ATE250057T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98114524 1998-08-03
PCT/EP1999/005277 WO2000008019A1 (en) 1998-08-03 1999-07-23 Process for the synthesis of (1h)-benzo[c]quinolizin-3-ones derivatives

Publications (1)

Publication Number Publication Date
ATE250057T1 true ATE250057T1 (de) 2003-10-15

Family

ID=8232396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99941269T ATE250057T1 (de) 1998-08-03 1999-07-23 Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten

Country Status (28)

Country Link
US (1) US6723850B1 (de)
EP (1) EP1102765B1 (de)
JP (1) JP2002522435A (de)
KR (1) KR100624239B1 (de)
CN (1) CN1128148C (de)
AT (1) ATE250057T1 (de)
AU (1) AU751873B2 (de)
BG (1) BG65062B1 (de)
BR (1) BR9912870A (de)
CA (1) CA2338498C (de)
CZ (1) CZ291648B6 (de)
DE (1) DE69911430T2 (de)
DK (1) DK1102765T3 (de)
EA (1) EA003997B1 (de)
EE (1) EE04642B1 (de)
ES (1) ES2203169T3 (de)
HU (1) HUP0103241A3 (de)
IL (2) IL141212A0 (de)
NO (1) NO20010559L (de)
NZ (1) NZ509243A (de)
PL (1) PL198963B1 (de)
PT (1) PT1102765E (de)
SI (1) SI1102765T1 (de)
SK (1) SK285438B6 (de)
TR (1) TR200100286T2 (de)
UA (1) UA67787C2 (de)
WO (1) WO2000008019A1 (de)
ZA (1) ZA200100365B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2881078C (en) 2004-06-24 2018-10-02 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
US8354427B2 (en) * 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
WO2007075901A2 (en) * 2005-12-24 2007-07-05 Vertex Pharmaceuticals Incorporated Quinolin- 4 - one derivatives as modulators of abc transporters
LT1993360T (lt) 2005-12-28 2017-06-12 Vertex Pharmaceuticals Incorporated N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
SI3330255T1 (sl) 2009-03-20 2021-03-31 Vertex Pharmaceuticals Incorporated Postopek izdelave regulatorja transmembranske prevodnosti pri cistični fibrozi
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
CA2820934C (en) * 2010-12-14 2019-04-09 Syngenta Participations Ag Strigolactam derivatives and their use as plant growth regulators
EP2819670B1 (de) 2012-02-27 2026-05-20 Vertex Pharmaceuticals Incorporated Pharmazeutische zubereitung und deren verabreichungen
CA2963945C (en) 2014-10-07 2023-01-10 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
CN105001216B (zh) * 2015-07-08 2017-03-01 中国科学院兰州化学物理研究所 一种喹嗪酮的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064961A (en) * 1989-12-18 1991-11-12 E. R. Squibb & Sons, Inc. Process for preparing an optically active cyclobutane nucleoside
FR2696465B1 (fr) * 1992-10-02 1994-12-23 Adir Nouveaux dérivés d'ellipticine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IT1286545B1 (it) * 1996-02-09 1998-07-15 Antonio Guarna Derivati benzo(c) chinolizinici,loro preparazione ed uso come inibitori delle 5-alfa-riduttasi
JPH09316076A (ja) * 1996-05-24 1997-12-09 Nippon Paper Ind Co Ltd 9−置換プリン誘導体及びその抗ウイルス剤としての用途

Also Published As

Publication number Publication date
ZA200100365B (en) 2001-07-26
CN1311788A (zh) 2001-09-05
PL345802A1 (en) 2002-01-02
EE04642B1 (et) 2006-06-15
CA2338498A1 (en) 2000-02-17
EP1102765B1 (de) 2003-09-17
CZ291648B6 (cs) 2003-04-16
IL141212A0 (en) 2002-03-10
EA003997B1 (ru) 2003-12-25
HK1037368A1 (en) 2002-02-08
EA200100213A1 (ru) 2001-08-27
NO20010559D0 (no) 2001-02-01
IL141212A (en) 2006-12-31
DK1102765T3 (da) 2004-02-02
TR200100286T2 (tr) 2001-07-23
DE69911430D1 (de) 2003-10-23
EE200100060A (et) 2002-06-17
SI1102765T1 (en) 2003-12-31
WO2000008019A1 (en) 2000-02-17
KR100624239B1 (ko) 2006-09-13
NZ509243A (en) 2002-11-26
HUP0103241A2 (hu) 2002-01-28
CA2338498C (en) 2009-05-19
CN1128148C (zh) 2003-11-19
JP2002522435A (ja) 2002-07-23
AU6312399A (en) 2000-02-28
NO20010559L (no) 2001-02-01
KR20010074684A (ko) 2001-08-09
AU751873B2 (en) 2002-08-29
US6723850B1 (en) 2004-04-20
BR9912870A (pt) 2001-10-16
ES2203169T3 (es) 2004-04-01
PT1102765E (pt) 2003-12-31
CZ2001434A3 (cs) 2001-08-15
UA67787C2 (uk) 2004-07-15
SK285438B6 (sk) 2007-01-04
DE69911430T2 (de) 2004-07-22
EP1102765A1 (de) 2001-05-30
BG105198A (en) 2001-12-29
PL198963B1 (pl) 2008-08-29
BG65062B1 (bg) 2007-01-31
SK1672001A3 (en) 2001-08-06
HUP0103241A3 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
DE69711395D1 (de) Verfahren zur herstellung von cyclohexen-carboxylatderivate
DE69910562D1 (de) Verfahren zur herstellung von derivaten der 6-cyanomethyl-1,3-dioxan-4-essigsäure
DE69911430D1 (de) Verfahren zur herstellung von 1-(1h)-benzoquinolizin-3-on derivaten
ATE270275T1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
DE502004010100D1 (de) Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substituierten Derivativen desselben
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
DE69922999D1 (de) Verfahren zur herstellung von polyhalogenierten para-trifluoroanilinen
ATE342254T1 (de) Verfahren zur herstellung von derivaten von [(1,5-diaryl)pyrazol-3-ylöpropansäure
ATE425143T1 (de) Verfahren zur herstellung von indolen
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
DE60225338D1 (de) Verfahren zur herstellung von derivaten von 3,3-dimethyl-2-formylcyclopropanekarbonsäure
ATE281428T1 (de) Verfahren zur herstellung von methoxyimino- essigsäureamiden
DE50107619D1 (de) Verfahren zur herstellung von 4-brom-anilin-derivaten
DE602004027401D1 (de) Verfahren zur herstellung von polymorphen von sertralin hydrochlorid
ATE297478T1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
DE69818431D1 (de) Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
ATE227735T1 (de) Verfahren zur herstellung von 4,4- dimethyl - 3beta- hydroxypregna -8,14-dien-21- carbonsäureestern und zwischenprodukte im verfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1102765

Country of ref document: EP

REN Ceased due to non-payment of the annual fee